Published in Sci Rep on September 07, 2016
Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell (2000) 7.87
AMP-activated protein kinase--development of the energy sensor concept. J Physiol (2006) 4.93
Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. Cell Metab (2006) 4.64
Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle. J Biol Chem (2003) 3.58
Mammalian AMP-activated protein kinase subfamily. J Biol Chem (1996) 3.47
Contraction-induced changes in acetyl-CoA carboxylase and 5'-AMP-activated kinase in skeletal muscle. J Biol Chem (1997) 2.54
Osteoclast-osteoblast communication. Arch Biochem Biophys (2008) 2.22
AMPK: a metabolic gauge regulating whole-body energy homeostasis. Trends Mol Med (2008) 2.16
Mammalian AMP-activated protein kinase is homologous to yeast and plant protein kinases involved in the regulation of carbon metabolism. J Biol Chem (1994) 2.04
The contribution of bone to whole-organism physiology. Nature (2012) 2.03
Characterization of AMP-activated protein kinase beta and gamma subunits. Assembly of the heterotrimeric complex in vitro. J Biol Chem (1996) 1.98
Thienopyridone drugs are selective activators of AMP-activated protein kinase beta1-containing complexes. Chem Biol (2008) 1.93
Suppressive function of androgen receptor in bone resorption. Proc Natl Acad Sci U S A (2003) 1.72
Subunit composition of AMPK trimers present in the cytokinetic apparatus: Implications for drug target identification. Cell Cycle (2012) 1.57
Non-catalytic beta- and gamma-subunit isoforms of the 5'-AMP-activated protein kinase. J Biol Chem (1996) 1.37
Osteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture. Eur J Pharmacol (2006) 1.20
Human mesenchymal stem cells (hMSCs) target osteosarcoma and promote its growth and pulmonary metastasis. Cancer Lett (2009) 1.20
Increased alpha2 subunit-associated AMPK activity and PRKAG2 cardiomyopathy. Circulation (2005) 1.18
Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression. Biochem Biophys Res Commun (2008) 1.14
AMP-activated protein kinase (AMPK) activation regulates in vitro bone formation and bone mass. Bone (2010) 1.11
Adiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cells. BMC Cell Biol (2007) 1.10
Effect of metformin on bone marrow progenitor cell differentiation: in vivo and in vitro studies. J Bone Miner Res (2010) 1.08
Mineralization and bone resorption are regulated by the androgen receptor in male mice. J Bone Miner Res (2009) 1.04
AMPK-beta1 subunit is a p53-independent stress responsive protein that inhibits tumor cell growth upon forced expression. Carcinogenesis (2003) 1.04
Osteoblast deletion of exon 3 of the androgen receptor gene results in trabecular bone loss in adult male mice. J Bone Miner Res (2007) 1.03
Human mesenchymal stem cells promote growth of osteosarcoma: involvement of interleukin-6 in the interaction between human mesenchymal stem cells and Saos-2. Cancer Sci (2010) 1.02
Metformin induces osteoblast differentiation via orphan nuclear receptor SHP-mediated transactivation of Runx2. Bone (2010) 1.00
Osteoblast differentiation is functionally associated with decreased AMP kinase activity. J Cell Physiol (2009) 0.99
Germline deletion of AMP-activated protein kinase beta subunits reduces bone mass without altering osteoclast differentiation or function. FASEB J (2009) 0.99
Activation of AMP kinase and inhibition of Rho kinase induce the mineralization of osteoblastic MC3T3-E1 cells through endothelial NOS and BMP-2 expression. Am J Physiol Endocrinol Metab (2008) 0.95
Brief review of models of ectopic bone formation. Stem Cells Dev (2012) 0.95
The role of CCAAT/enhancer binding protein (C/EBP)-alpha in osteogenesis of C3H10T1/2 cells induced by BMP-2. J Cell Mol Med (2009) 0.89
Mutation in osteoactivin decreases bone formation in vivo and osteoblast differentiation in vitro. Am J Pathol (2014) 0.85
Genetic deletion of catalytic subunits of AMP-activated protein kinase increases osteoclasts and reduces bone mass in young adult mice. J Biol Chem (2013) 0.85
The CREB-Smad6-Runx2 axis contributes to the impaired osteogenesis potential of bone marrow stromal cells in fibrous dysplasia of bone. J Pathol (2012) 0.83
AMPK α2 subunit is involved in platelet signaling, clot retraction, and thrombus stability. Blood (2010) 0.82
AMPKβ subunits: more than just a scaffold in the formation of AMPK complex. FEBS J (2013) 0.81
Osteoactivin promotes osteoblast adhesion through HSPG and αvβ1 integrin. J Cell Biochem (2014) 0.80
The reduced trabecular bone mass of adult ARKO male mice results from the decreased osteogenic differentiation of bone marrow stroma cells. Biochem Biophys Res Commun (2011) 0.79
Loss of androgen receptor promotes adipogenesis but suppresses osteogenesis in bone marrow stromal cells. Stem Cell Res (2013) 0.78
AMPK promotes osteogenesis and inhibits adipogenesis through AMPK-Gfi1-OPN axis. Cell Signal (2016) 0.77
Androgen receptor agonism promotes an osteogenic gene program in preadipocytes. Biochem Biophys Res Commun (2013) 0.76
Gene expression profiles and phosphorylation patterns of AMP-activated protein kinase subunits in various mesenchymal cell types. Chin Med J (Engl) (2014) 0.76
AMPK promotes osteogenesis and inhibits adipogenesis through AMPK-Gfi1-OPN axis. Cell Signal (2016) 0.77